Metropolitan Capital Advisors’s Elevance Health ELV Stock Holding History

Metropolitan Capital Advisors’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$4.68M	Sell	33,562 -12,375	-27%	-$1.7M	9.3%	2
2015 Q3	$6.43M	Buy	45,937 +200	+0.4%	+$30.1K	5.91%	4
2015 Q2	$7.51M	Sell	45,737 -200	-0.4%	-$32K	5.95%	3
2015 Q1	$7.09M	Hold	45,937	–	–	6.18%	4
2014 Q4	$5.77M	Sell	45,937 -1,100	-2%	-$136K	5.51%	4
2014 Q3	$5.63M	Sell	47,037 -1,400	-3%	-$161K	5.09%	5
2014 Q2	$5.21M	Buy	48,437 +4,300	+10%	+$443K	3.98%	7
2014 Q1	$4.39M	Sell	44,137 -922	-2%	-$83.4K	3.87%	6
2013 Q4	$4.16M	Sell	45,059 -15,621	-26%	-$1.39M	4.43%	8
2013 Q3	$5.07M	Sell	60,680 -4,894	-7%	-$419K	5.6%	6
2013 Q2	$5.37M	Buy	+65,574	New	+$4.91M	6.81%	3

Other funds holding ELV

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Metropolitan Capital Advisors's ELV Position: Q4 2015 in Review

Metropolitan Capital Advisors reduced its Elevance Health (ELV) stake by 27% in Q4 2015, selling an estimated $1.7M and leaving 33,562 shares worth $4.68M. The position accounts for 9.3% of the portfolio, ranked #2.

Metropolitan Capital Advisors first reported a position in ELV in Q2 2013 and has held it in 11 quarters since. The position peaked at $7.51M in Q2 2015. 765 funds tracked by Wall St. Rank hold ELV as of Q4 2015.

Metropolitan Capital Advisors held 33,562 shares of Elevance Health worth $4.68M as of Q4 2015.
Metropolitan Capital Advisors sold 12,375 Elevance Health shares in Q4 2015, an estimated $1.7M.
Elevance Health made up 9.3% of Metropolitan Capital Advisors's portfolio in Q4 2015, its #2 holding.
Metropolitan Capital Advisors first reported a position in Elevance Health in Q2 2013 and has held it in 11 quarters since.
Metropolitan Capital Advisors's Elevance Health position peaked at $7.51M in Q2 2015.
765 funds tracked by Wall St. Rank held Elevance Health as of Q4 2015.

Based on Metropolitan Capital Advisors's 13F filing for Q4 2015, filed 16 Feb 2016.